We are pleased to announce that our DeepChek® Assay 13-Plex KB Drug Susceptibility Testing, intended to be used for Tuberculosis Drug Resistance assessment through NGS sequencing, is now CE-IVD marked !
ABL DIAGNOSTICS S.A.
42, rue Olivier Métra – Bat E1
75020, PARIS FRANCE
Phone : +33 145 061 574
Email :
Email 2 :